Triple Positive Breast Cancer

Triple positive breast cancer is a unique form of breast cancer where cancer cells respond to three specific factors: estrogen, progesterone, and a protein called HER2. While this diagnosis once meant facing an aggressive cancer with limited options, today’s treatments have transformed the outlook, offering multiple effective ways to fight the disease.

Table of contents

• What is Triple Positive Breast Cancer?
• How Common is This Type of Cancer?
• Signs and Symptoms
• What Causes Triple Positive Breast Cancer?
• How Doctors Diagnose This Cancer
• Understanding Cancer Stages
• Treatment Options
• Outlook and Prognosis

What is Triple Positive Breast Cancer?

Triple positive breast cancer is a specific subtype of breast cancer where cancer cells have three important characteristics. The cells contain receptors, which are special proteins on the cell surface that act like doorways, allowing certain substances to enter and affect the cell^[2].

A cancer is considered triple positive when laboratory tests show that the cancer cells have^[2][3]:

• Estrogen receptors (ER-positive): The cancer cells grow in response to the hormone estrogen
• Progesterone receptors (PR-positive): The cancer cells grow in response to the hormone progesterone
• Too many HER2 proteins (HER2-positive): The cancer cells have excess amounts of a protein called human epidermal growth factor receptor 2, which fuels their growth

When hormones bind to their receptors on cancer cells, they send signals telling the cell to grow. Similarly, too many HER2 proteins make breast cells grow and divide in an uncontrolled way^[2].

Triple positive breast cancer is classified as a unique subtype within luminal breast cancer, which refers to cancers that start in the inner lining cells of breast ducts and respond to hormones^[4][8].

How Common is This Type of Cancer?

Triple positive breast cancer accounts for approximately 5 to 10 percent of all breast cancer cases^[3][4][8]. Some sources report that about 10 in every 100 women diagnosed with breast cancer have this specific type^[3].

This relatively rare subtype is characterized by the presence of all three markers—estrogen receptors, progesterone receptors, and excess HER2 protein—which makes it distinct from other breast cancer subtypes^[4].

Signs and Symptoms

The symptoms of triple positive breast cancer are the same as most other types of breast cancer. The most common sign is finding a new lump or mass in the breast or underarm area^[2][3].

It’s important to understand that not all breast lumps are cancerous—some can be benign, meaning they are not cancer. Only a healthcare provider can determine whether a lump is cancerous or benign through proper examination and testing. This is why it’s essential to get checked by a doctor if you discover a new lump^[3].

What Causes Triple Positive Breast Cancer?

Triple positive breast cancer develops when a normal breast cell transforms into a cancer cell through genetic changes called mutations. Scientists don’t fully understand what triggers these mutations^[3].

What researchers do know is that both normal breast cells and triple positive cancer cells have hormone receptors and HER2 proteins on their surfaces. In healthy cells, these features help control normal cell growth and development. However, in cancer cells, these same features allow the cells to multiply uncontrollably. The cancer cells may form a tumor, and without treatment, the cancer can spread to other parts of the body^[3].

The risk factors for developing triple positive breast cancer are the same as for breast cancer in general. For example, the risk of breast cancer increases with age. Having mutations in genes called BRCA1 or BRCA2, which are inherited from a biological parent, also increases the risk^[3].

However, it’s important to note that most people with breast cancer don’t have these inherited gene mutations. Triple positive breast cancer is not typically hereditary. In most cases, the genetic changes that lead to this cancer happen during a person’s lifetime rather than being passed down from parents^[3].

How Doctors Diagnose This Cancer

Like other types of breast cancer, the diagnostic process for triple positive breast cancer typically begins with imaging tests. Mammograms, which are X-ray images of the breast, or breast MRI scans, which use magnetic waves to create detailed pictures, are often the first steps in identifying an abnormal area in the breast^[2].

If imaging tests suggest the presence of cancer, doctors will recommend a biopsy. During this procedure, a small sample of tissue is removed from the suspicious area and sent to a laboratory. The biopsy serves two important purposes: first, it confirms whether cancer is present, and second, it helps identify the specific type of cancer^[2][3].

To diagnose triple positive breast cancer specifically, laboratory specialists examine the tissue sample under a microscope. They perform tests to check for the presence of estrogen receptors, progesterone receptors, and the amount of HER2 proteins on the cancer cells. If the tissue shows all three markers—estrogen receptors, progesterone receptors, and excess HER2—the diagnosis is triple positive breast cancer^[2][3].

Doctors may also test the lymph nodes, which are small bean-shaped structures that are part of the body’s immune system. Cancer can sometimes spread to nearby lymph nodes, so checking them helps doctors understand how far the cancer may have spread^[3].

Understanding Cancer Stages

After confirming a diagnosis of triple positive breast cancer, doctors need to determine how much the cancer has spread. This process is called staging. The stage of cancer helps doctors plan the most effective treatment approach^[3].

To stage the cancer, doctors use additional imaging tests to see where the cancer is located in the body and whether it has spread beyond the breast. They also consider the size and grade of the tumor—which describes how abnormal the cancer cells look under a microscope—and whether cancer cells are found in the lymph nodes^[2][3].

Breast cancer stages are typically written using Roman numerals from I to IV. Lower numbers indicate cancer that is confined to a smaller area, while higher numbers mean the cancer has spread more widely^[2].

Stage IV breast cancer is also called metastatic breast cancer. This term means the cancer has spread to parts of the body away from the breast, such as the liver, bones, or other organs^[2].

Treatment Options

Triple positive breast cancer can be treated using several different approaches. Because the cancer responds to three different factors—estrogen, progesterone, and HER2—doctors typically recommend a combination of treatments. The specific treatment plan depends on the stage of the cancer and the individual patient’s situation^[2][3].

Surgery

Surgery is the most common initial treatment for triple positive breast cancer. The goal is to remove the tumor from the breast. There are two main surgical options^[2][3]:

• Lumpectomy: The surgeon removes only the tumor and a small amount of surrounding tissue
• Mastectomy: The surgeon removes the entire breast

Chemotherapy

Chemotherapy uses powerful medicines to kill cancer cells throughout the body. For triple positive breast cancer, chemotherapy can be given before surgery to shrink the tumor, making it easier to remove. It can also be given after surgery to destroy any cancer cells that may have been left behind^[2][3].

Radiation Therapy

Radiation therapy uses high-energy rays to kill cancer cells in a specific area. If a patient has a lumpectomy, doctors usually recommend radiation therapy afterward to destroy any remaining cancer cells in the breast. Depending on the size of the cancer and whether it has spread to lymph nodes, radiation may also be recommended after mastectomy. For patients with metastatic disease, radiation can help ease pain or control cancer in a specific area^[2].

Targeted Therapy

Because triple positive breast cancer has too many HER2 receptors, it responds well to medicines that specifically target the HER2 protein. These are called targeted therapies. Examples include medicines known by their brand names Herceptin (chemical name: trastuzumab) and Perjeta (chemical name: pertuzumab)^[2].

Targeted therapy is often combined with chemotherapy. This combination approach is recommended for some stage I cancers and for most stage II and stage III triple positive breast cancers^[2].

Hormonal Therapy

Because triple positive breast cancer has receptors for both estrogen and progesterone, hormonal therapy medicines work well against this type of cancer. These medicines block hormones from reaching cancer cells or lower the amount of hormones in the body^[2].

Common hormonal therapy medicines include tamoxifen and a group of drugs called aromatase inhibitors. Hormonal therapy is prescribed for all triple positive breast cancers, regardless of stage^[2].

A Multimodal Approach

Recent research has shown that treating triple positive breast cancer requires strategies that target multiple pathways in cancer cells. Because of the complex interactions between the estrogen receptor and HER2 signaling pathways, combining different types of treatment—what doctors call a multimodal approach—has emerged as an important way to overcome treatment resistance and improve outcomes^[4][8].

Outlook and Prognosis

In the past, triple positive breast cancer was considered one of the more difficult breast cancers to treat. This was because cancers with too much HER2 protein tend to be aggressive, meaning they grow and spread quickly^[3].

However, the outlook for people with triple positive breast cancer has improved dramatically. Today’s treatments effectively fight cancers with excess HER2. There are many medicines available to treat triple positive breast cancer, targeting the cancer through multiple approaches—blocking HER2, blocking hormones, and destroying cancer cells directly^[2][3].

Thanks to advances in treatment, people with triple positive breast cancer are living longer, healthier lives. Many patients are able to achieve remission, meaning there is no detectable cancer in their body, and can live cancer-free for many years^[3].

The key to a good outcome is early detection and receiving appropriate treatment that targets all three characteristics of the cancer—the estrogen receptors, progesterone receptors, and HER2 protein. Working closely with a medical team experienced in treating this specific subtype of breast cancer is essential for achieving the best possible results^[2][4].